FDA Grants Full Approval for Tivdak to Treat Recurrent or Metastatic Cervical Cancer

NEW YORK& COPENHAGEN, Denmark--(BUSINESS WIRE) April 29, 2024 -- Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) today announced the U.S. Food and Drug Administration (FDA) approves the supplemental Biologics License Application (sBLA)...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news